Abstract:Chronic kidney disease (CKD) represents a major public health challenge, and its core pathological feature is podocyte injury. As terminally differentiated cells, podocytes are difficult to regenerate, making them a critical target for CKD prevention and treatment. The adriamycin-induced nephropathy (AN) model specifically induces podocyte injury, effectively mimicking key characteristics of human CKD, including proteinuria and glomerulosclerosis. Recent studies have identified transfer RNA-derived fragments (tRFs) as a novel class of non-coding RNAs that play important regulatory roles in podocyte injury. This review summarizes the mechanisms by which specific tRFs, such as tRF-003634, tRF-013354 and tRF-011690, mediate podocyte inflammation, apoptosis, and cytoskeletal remodeling through the modulation of signaling pathways including TLR4/NF-κB and Wnt/β-catenin. These findings reveal new functions of tRFs, provide insights into the pathogenesis of CKD, and highlight both the value and the challenges of their application as biomarkers and therapeutic targets.